Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) FCF Margin (2016 - 2025)

Traws Pharma (TRAW) has disclosed FCF Margin for 14 consecutive years, with 218.77% as the latest value for Q2 2025.

  • For Q2 2025, FCF Margin rose 1706544.0% year-over-year to 218.77%; the TTM value through Dec 2025 reached 651.79%, up 1253051.0%, while the annual FY2025 figure was 744.44%, 1405202.0% up from the prior year.
  • FCF Margin hit 218.77% in Q2 2025 for Traws Pharma, up from 9538.6% in the prior quarter.
  • Across five years, FCF Margin topped out at 218.77% in Q2 2025 and bottomed at 20133.33% in Q3 2024.
  • Average FCF Margin over 5 years is 8744.54%, with a median of 7755.89% recorded in 2022.
  • Year-over-year, FCF Margin plummeted -1229298bps in 2024 and then surged 1706544bps in 2025.
  • Traws Pharma's FCF Margin stood at 7616.07% in 2021, then increased by 9bps to 6935.71% in 2022, then decreased by -14bps to 7910.71% in 2023, then increased by 9bps to 7214.29% in 2024, then surged by 97bps to 218.77% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 218.77%, 9538.6%, and 7214.29% for Q2 2025, Q1 2025, and Q4 2024 respectively.